Medicover AB (publ) (0RPS.L)

SEK 242.0

(0.05%)

Operating Expenses Summary of Medicover AB (publ)

Medicover AB (publ)'s latest annual operating expenses in 2023 was 298 Million EUR , up 7.04% from previous year.
Medicover AB (publ)'s latest quarterly operating expenses in 2024 Q2 was 88.6 Million EUR , up 3.5% from previous quarter.
Medicover AB (publ) reported a annual operating expenses of 278.6 Million EUR in annual operating expenses 2022, up 18.25% from previous year.
Medicover AB (publ) reported a annual operating expenses of 235.6 Million EUR in annual operating expenses 2021, up 19.17% from previous year.
Medicover AB (publ) reported a quarterly operating expenses of 88.6 Million EUR for 2024 Q2, up 3.5% from previous quarter.
Medicover AB (publ) reported a quarterly operating expenses of 75.7 Million EUR for 2023 Q3, down -0.66% from previous quarter.

Annual Operating Expenses Chart of Medicover AB (publ) (2023 - 2014)

Historical Annual Operating Expenses of Medicover AB (publ) (2023 - 2014)

Year	Operating Expenses	Operating Expenses Growth
2023	298 Million EUR	7.04%
2022	278.6 Million EUR	18.25%
2021	235.6 Million EUR	19.17%
2020	197.7 Million EUR	23.56%
2019	160 Million EUR	21.86%
2018	131.3 Million EUR	15.99%
2017	113.2 Million EUR	14.46%
2016	98.9 Million EUR	24.87%
2015	79.2 Million EUR	11.71%
2014	70.9 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	85.6 Million EUR	27.38%
2024 Q2	88.6 Million EUR	3.5%
2023 Q3	75.7 Million EUR	-0.66%
2023 Q1	79.1 Million EUR	9.71%
2023 Q4	67.2 Million EUR	-11.23%
2023 Q2	76.2 Million EUR	-3.67%
2023 FY	298.2 Million EUR	7.04%
2022 Q3	72.5 Million EUR	15.63%
2022 FY	278.6 Million EUR	18.25%
2022 Q4	72.1 Million EUR	-0.55%
2022 Q2	62.7 Million EUR	-12.06%
2022 Q1	71.3 Million EUR	5.47%
2021 FY	235.6 Million EUR	19.17%
2021 Q2	57.3 Million EUR	3.99%
2021 Q3	55.6 Million EUR	-2.97%
2021 Q4	67.6 Million EUR	21.58%
2021 Q1	55.1 Million EUR	21.9%
2020 Q3	48.6 Million EUR	-4.14%
2020 Q4	45.2 Million EUR	-7.0%
2020 FY	197.7 Million EUR	23.56%
2020 Q1	53.2 Million EUR	24.59%
2020 Q2	50.7 Million EUR	-4.7%
2019 FY	160 Million EUR	21.86%
2019 Q4	42.7 Million EUR	10.34%
2019 Q3	38.7 Million EUR	-0.26%
2019 Q2	38.8 Million EUR	-2.51%
2019 Q1	39.8 Million EUR	11.8%
2018 Q3	32 Million EUR	-0.93%
2018 Q4	35.6 Million EUR	11.25%
2018 Q1	31.4 Million EUR	10.18%
2018 FY	131.3 Million EUR	15.99%
2018 Q2	32.3 Million EUR	2.87%
2017 Q1	27.9 Million EUR	10.71%
2017 Q3	27.9 Million EUR	-3.13%
2017 Q2	28.8 Million EUR	3.23%
2017 FY	113.2 Million EUR	14.46%
2017 Q4	28.5 Million EUR	2.15%
2016 Q1	22.7 Million EUR	0.0%
2016 Q3	23.7 Million EUR	-13.5%
2016 Q2	27.4 Million EUR	20.7%
2016 Q4	25.2 Million EUR	6.33%
2016 FY	98.9 Million EUR	24.87%
2015 FY	79.2 Million EUR	11.71%
2014 FY	70.9 Million EUR	0.0%

Peer Operating Expenses Comparison of Medicover AB (publ)

Name	Operating Expenses	Operating Expenses Difference
Xvivo Perfusion AB (publ)	440.92 Million SEK	32.415%